The predictive value of partialMGMTpromoter methylation for IDH-wild-type glioblastoma patients is a research paper published in Neuro-Oncology Practice (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: F32CA257210
National Institutes of Health
Grant: K12CA090354
National Institutes of Health
Grant: 1F32CA257210-01
The role of cellular senescence in chemotherapy-related cognitive impairment
National Institutes of Health
Grant: 2K12CA090354-21
Training Program in Nervous System Tumors
FWCI
0.82
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals